Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15852306 | 0.96 | PRKDC (0.33) | PRKDCCYP1A1CYP1A2CYP1B1KDM4E | |
| SCHEMBL21870288 | 0.93 | ALDH1A1 (0.31) | ALDH1A1MAPTHPGD | |
| SCHEMBL24223319 | 0.91 | MAPT (0.31) | PRKDCMAPT | |
| SCHEMBL15852310 | 0.91 | PRKDC (0.33) | PRKDCCYP1A2KDM4EALDH1A1TP53 | |
| SCHEMBL15851740 | 0.90 | — | — | |
| SCHEMBL15852307 | 0.90 | PRKDC (0.36) | PRKDCCYP1A2KDM4EALDH1A1TP53 | |
| SCHEMBL15852074 | 0.89 | ALOX5 (0.32) | PRKDCCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL15852314 | 0.89 | ALDH1A1 (0.33) | PRKDCCYP1A2KDM4EALDH1A1TP53 | |
| SCHEMBL15851827 | 0.89 | CYP1A1 (0.31) | TDP1CYP1A1CYP1A2CYP1B1KDM4E | |
| SCHEMBL25035721 | 0.88 | PRKDC (0.31) | PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200111973-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200111973-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME | RER1, RPS19, MRPS22 | PRKDC 4410/4885TDP1 2314/4885CYP1A1 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.